ArticlePloS one2017

Cryptosporidium parvum vaccine candidates are incompletely modified with O-linked-N-acetylgalactosamine or contain N-terminal N-myristate and S-palmitate.

John R Haserick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.